Latest news | Page 66

In summary, paranoia is a troubling symptom that arises from psychiatric disorders like schizophrenia and delusional disorder. Conventional treatments with antipsychotics, psychotherapy and hospitalization have varying degrees of efficacy and risks.

> Read more

 

Getting good quality sleep on a regular basis is essential for both physical and mental health. Many people struggle with different sleep disorders that disrupt sleep. Research indicates that cannabinoids CBD and CBG may help improve different aspects of sleep in some individuals.

> Read more

 

While early research on both compounds is promising, more studies are still needed. But based on current evidence and user anecdotes, judicious use of CBD and CBG does appear helpful for providing naturally-sourced wakefulness, focus and motivation.

> Read more

 

Current evidence and pharmacology principles indicate significant potential for CBG to interact with many common pharmaceutical medications based on overlapping metabolism and effects on biological pathways like platelet function, neurotransmitters, and cytochrome P450 enzymes.

> Read more

 

In summary, current preclinical studies strongly support the potential muscle-relaxing properties of CBG oil based on its apparent ability to reduce spasticity, cramping, tightness, soreness and pain through various direct and indirect mechanisms involving endocannabinoid receptors and neural pathways.

> Read more

 

While formal clinical trials are still needed, initial preclinical studies and anecdotal reports suggest promising therapeutic potential for the cannabis compound CBG to help manage ADHD symptoms. By modulating key neurotransmitters and providing anti-inflammatory and anxiolytic effects, CBG may improve focus, motivation, impulsivity and hyperactivity in some cases.

> Read more